Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5457126 | NOVARTIS | Use of lodoxamide to treat ophthalmic allergic conditions |
Oct, 2012
(11 years ago) |
Market Authorisation Date: 23 September, 1993
Treatment: Treatment of ocular allergic response in human eyes
Dosage: SOLUTION/DROPS;OPHTHALMIC